Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 2 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 12234295

    Chimeric transmembrane protein comprising antibody dimerization domains and a type I cytokine receptor endodomain, encoding nucleic acids thereof and methods of use thereof

    AUTOLUS LIMITED · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  2. US 12233090

    Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19

    The Regents of the University of California · Granted Feb 25, 2025 · Expires Feb 20, 2045

    granted
  3. US 12226435

    Bispecific OR-gate chimeric antigen receptor responsive to CD20 and CD19

    The Regents of the University of California · Granted Feb 18, 2025 · Expires Feb 13, 2045

    granted
  4. US 12221462

    Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells

    Allogene Therapeutics, Inc. · Granted Feb 11, 2025 · Expires Feb 6, 2045

    granted
  5. US 12215162

    BAFF-R targeted chimeric antigen receptor-modified T-cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  6. US 12215347

    Chimeric antigen receptors with enhanced signaling and activities and uses thereof

    Allogene Therapeutics, Inc. · Granted Feb 4, 2025 · Expires Jan 30, 2045

    granted
  7. US 12202902

    FLT3-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 21, 2025 · Expires Jan 16, 2045

    granted
  8. US 12186363

    Compositions and methods for dengue virus chimeric constructions in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  9. US 12186375

    Factor VIII chimeric and hybrid polypeptides, and methods of use thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Jan 7, 2025 · Expires Jan 2, 2045

    granted
  10. US 12180484

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2024 · Expires Dec 26, 2044

    granted
  11. US 12163169

    Inducible chimeric cytokine receptors

    Allogene Therapeutics, Inc. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  12. US 12161672

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  13. US 12161696

    Methods of treating hemophilic arthropathy using chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Dec 10, 2024 · Expires Dec 5, 2044

    granted
  14. US 12150959

    Chimeric antigen receptors with BCMA specificity and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 26, 2024 · Expires Nov 21, 2044

    granted
  15. US 12139522

    T-cells comprising two different chimeric antigen receptors and uses thereof

    THE MEDICAL RESEARCH INFRASTRUCTURE AND HEAL SERVICED FUND OF THE TEL AVIV MEDECAL CENTER · Granted Nov 12, 2024 · Expires Nov 7, 2044

    granted
  16. US 12121542

    BCMA chimeric antigen receptor based on single domain antibody and use thereof

    SHENZHEN PREGENE BIOPHARMA CO., LTD. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  17. US 12122846

    Chimeric antigen receptor for tumor targeting

    Fate Therapeutics, Inc. · Granted Oct 22, 2024 · Expires Oct 17, 2044

    granted
  18. US 12084514

    Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof

    The Board of Regents of the University of Oklahoma · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  19. US 12084497

    SIRP1α targeted chimeric proteins and uses thereof

    Orionis Biosciences, Inc · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  20. US 12077785

    Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereof

    SOTIO BIOTECH INC. · Granted Sep 3, 2024 · Expires Aug 29, 2044

    granted
  21. US 12071632

    Chimeric vectors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  22. US 12065498

    Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same

    Cell Design Labs, Inc. · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  23. US 12065479

    Force sensor cleavage domain containing chimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  24. US 12065490

    Chimeric antigen receptors and methods of making

    The Board of Regents of the University of Texas System · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted